Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Funding

In line with EMA’s criteria to be fulfilled by healthcare professionals’ organisations involved in European Medicines Agency activities, please find below an indication of funding sources for the European Society for Medical Oncology.

ESMO Funding Sources by Product 2020

Highest contribution by a single company: 12.31%* (percentage calculated on the overall Sponsorship Income)

*(This percentage reflects the extenuating circumstances during 2020, i.e. COVID-19)

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.